Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    BARDA Announces CBRN Medical Countermeasures Conference

    By Global Biodefense StaffSeptember 28, 2012
    Share
    Facebook LinkedIn Reddit Email

    The Biomedical Advanced Research and Development Authority (BARDA) has announced an upcoming conference for industry to learn more about U.S. government medical countermeasure requirements, interact with BARDA, and network with other private sector colleagues. The event will take place Oct. 29-31 in Washington, D.C.

    BARDA supports the advanced research & development, manufacturing, acquisition, and stockpiling of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) WMD threats, pandemic influenza, and emerging infectious diseases.

    BARDA’s work is carried out as part of the Public Health Emergency Medical Countermeasure Enterprise (PHEMCE), a coordinated interagency effort that also includes three primary HHS agencies (NIH, FDA, and CDC), as well as the Departments of Homeland Security, Defense, Veteran’s Affairs, and Agriculture.

    Included in the conference agenda is information on the 2012 PHEMCE Strategic Implementation Plan and its goals for medical countermeasure development, manufacturing, approval for use, and deployment; and discussion of new initiatives designed to encourage novel and innovative approaches to the development of countermeasures.

    Conference participants may also request one-on-one meetings with BARDA program staff and Office of Acquisitions Management, Contracts and Grants (AMCG) contracting officers. Requests for such meetings should be submitted at the time of registration for the conference.

    Conference registration is now available at www.medicalcountermeasures.gov

    ASPR BARDA Events HHS
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleChilean Army Visits RDECOM, Edgewood Chemical and Biological Center
    Next Article Biodefense Headlines – September 30, 2012

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    SOREX Brings Top CBRNE Units to Dugway Proving Ground

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.